Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AIFM1P1 is a pseudogene related to the protein-coding gene Apoptosis-inducing factor, mitochondria-associated 1 (AIFM1). Pseudogenes such as AIFM1P1 are DNA sequences similar to known genes but are non-functional, do not code for active proteins, and are not considered valid therapeutic targets. While a pseudogene related to AIFM1 has been identified on chromosome 10[1][2][3][5], it does not have a demonstrated biological function, is not druggable, and is not involved in disease or cellular pathways. All known biological and disease associations refer to the protein-coding gene AIFM1, not to the pseudogene AIFM1P1. Key clarification: There is likely an error if AIFM1P1 is proposed as a therapeutic target, as it is a non-coding pseudogene rather than a protein-coding gene or functional receptor/enzyme. Information on function, interacting drugs, disease association, or mechanism of action only exists for AIFM1, not for AIFM1P1[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apoptosis-inducing factor, mitochondria-associated 1 pseudogene 1 (AIFM1P1).